Suven Pharmaceuticals Q4 Results

  • BSE: 543064
  • NSE: SUVENPHAR
  • ISIN: INE03QK01018
  • Sector: Biotechnology & Drugs
BSE
6452.65 (0.41%)
Volume271.00
Updated: Sat 18 May, 2024 | 12:21:43
NSE
645.71.55 (0.24%)
Volume6.84 K
Updated: Sat 18 May, 2024 | 12:46:28
Today: 644.40
649.30
52-Wk: 427.05
767.00

Q4 Results Highlights

    Note: Comparison is on QoQ basis

    Quarterly - Suven Pharmaceuticals Q4 Results

    *All figures in crores except per share values
    Fiscal PeriodMar 23Dec 22QoQ Comp
    Total Revenue 369.36353.774.41%
    Selling/ General/ Admin Expenses Total 25.6029.68-13.73%
    Depreciation/ Amortization 11.9612.24-2.29%
    Other Operating Expenses Total 15.7718.13-13.04%
    Total Operating Expense 212.24219.32-3.23%
    Operating Income 157.12134.4616.86%
    Net Income Before Taxes 166.21146.0813.78%
    Net Income 123.97107.7215.09%
    Diluted Normalized EPS 4.874.2315.03%

    Recommended For You

      More Recommendations

      Trending Stocks

        Subscribe to Our Newsletter

        Get daily newsletters around different themes from livemint.

        Subscribe
        HomeMarketsPremiumFor youGet App